Oxadiazole and its salts, their use in treating dementia
US5106853A · kind A · utility
67Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 1990 |
| Grant date | Apr 21, 1992 |
| Priority date | — |
| Expiry date | May 9, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The compound (3R, 4R)-3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1-azabicyclo[2.2.1]heptane and its salts behave as a functionally selective muscarinic agonist and are useful in the treatment of neurological and mental disorders, preferably in a pharmaceutical formulation comprising the active compound in association with a pharmaceutically acceptable carrier. The compound can be prepared by methods analogous to those known in the art via suitable chiral intermediates and cyclopropyl carboxamide oxime.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.